Search Within

David Norman Brown

Formats
  1. Journal Article (45)
  2. Meeting Abstract (45)
  3. Editorial (1)
Groups
  1. Sloan Kettering Institute Postdocs (91)
  2. Department of Pathology and Laboratory Medicine (81)
  3. GSK Faculty (71)
  4. GDMT, Pathology and Laboratory Medicine (70)
  5. Gynecology Disease Management Team (70)
  6. Department of Medicine (61)

More Groups

People
  1. Britta Weigelt (70)
  2. Jorge Reis-Filho (68)
  3. Fresia Pareja Zea (45)
  4. Pier Selenica (43)
  5. Arnaud Da Cruz Paula (41)
  6. Edi Brogi (26)

More People

Years
  1. 2025 (3)
  2. 2024 (14)
  3. 2023 (13)
  4. 2022 (5)
  5. 2021 (9)
  6. 2020 (14)

More Years

Publications
  1. Cancer Research (14)
  2. Laboratory Investigation (12)
  3. Gynecologic Oncology (8)
  4. npj Breast Cancer (7)
  5. Annals of Oncology (6)
  6. Modern Pathology (6)

More Publications

Publishers
  1. Nature Publishing Group (22)
  2. American Association for Cancer Research (20)
  3. Elsevier Inc. (10)
  4. Oxford University Press (9)
  5. Nature Research (7)
  6. Wiley Blackwell (6)

More Publishers

Results (91)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TROP2 expression and therapeutic targeting in uterine carcinosarcoma
    Journal Article

    Moufarrij, S.; Dopeso, H.; Brown, D. N.; Green, H.; Gill, K.; Tengelin, J.; Brodeur, M. N.; Zammarrelli, W. A. 3rd; Varice, N.; Wu, M.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Co-occurrence of PI3K pathway gene alterations in endometrial cancer molecular subtypes at the single cell level
    Meeting Abstract

    Da Cruz Paula, A.; Zhu, Y.; Brown, D.; Pareja, F.; de Oliveira, T. B.; Dopeso, H.; da Silva, E. M.; Chandarlapaty, S.; Abu-Rustum, N.; Reis, J.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • ERBB2 amplification occurs late in the pathogenesis of high-grade endometrial carcinomas with HER2 expression heterogeneity
    Meeting Abstract

    Chui, M. H.; Brown, D.; Ellenson, L.; Weigelt, B.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Long survival in patients with adnexal high-grade serous carcinoma who underwent suboptimal cytoreductive surgery: A whole-genome analysis
    Meeting Abstract

    Sullivan, M.; Brown, D.; Paula, A. D.; Boerner, T.; O'Cearbhaill, R.; Tew, W.; Grisham, R.; Sonoda, Y.; Leitao, M.; Broach, V.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • TROP2 as a novel target in uterine carcinosarcoma organoid models
    Meeting Abstract

    Moufarrij, S.; Dopeso, H.; Green, H.; Gill, K.; Brown, D.; Zammarrelli, W.; Varice, N.; Wu, M.; Paula, A. D.; de Oliveira, T. B.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Whole-genome sequencing-based genomic characterization of uterine serous carcinoma
    Meeting Abstract

    Andres, S.; Brown, D.; Da Cruz Paula, A.; Aghajanian, C.; Abu-Rustum, N.; Ellenson, L.; Weigelt, B.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Sensitivity of HER2-low uterine carcinosarcoma organoids to the antibody-drug conjugate, trastuzumab deruxtecan
    Meeting Abstract

    Moufarrij, S.; Dopeso, H.; Green, H.; Gill, K.; Brown, D.; Zammarrelli, W.; Varice, N.; Wu, M.; Paula, A. D.; de Oliveira, T. B.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Telomerase-independent genetic drivers of telomere lengthening in breast cancer
    Meeting Abstract

    Jalali Farahani, S.; Blanco-Heredia, J.; Brown, D.; Gazzo, A.; Selenica, P.; Dopeso, H.; da Silva, E. M.; Repetto, M.; Ross, D.; Mandelker, D.; more...
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Breast cancers harboring genetic alterations in the Wnt/beta-catenin signaling pathway
    Meeting Abstract

    Jalali Farahani, S.; Repetto, M.; Gazzo, A.; Dopeso, H.; Selenica, P.; da Silva, E. M.; Ross, D.; Brown, D.; Wen, H.; Zhang, H.; more...
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • A genomics-driven artificial intelligence–based model classifies breast invasive lobular carcinoma and discovers CDH1 inactivating mechanisms
    Journal Article

    Pareja, F.; Dopeso, H.; Wang, Y. K.; Gazzo, A. M.; Brown, D. N.; Banerjee, M.; Selenica, P.; Bernhard, J. H.; Derakhshan, F.; da Silva, E. M.; more...
    Cancer Research (2024)

    Fulltext@MSK | Save